Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

  • This share is currently suspended. It was suspended at a price of 47.50
  • There is currently no data for BAR

Directorate Change

18 Jun 2013 11:10

RNS Number : 2909H
Swallowfield PLC
18 June 2013
 

Swallowfield plc

("Swallowfield" or the "Company")

 

Appointment of Chief Executive

 

Swallowfield plc, the leading cosmetics, toiletries and household goods group, is delighted to announce the following Board appointment:

 

Mr Chris How is appointed as Chief Executive Officer of the Company, effective 15th July 2013. Chris has extensive international experience across the personal care and household sector, having held senior General Management and Sales & Marketing positions with PZ Cussons and Colgate Palmolive.

 

He has previously been Managing Director PZ Cussons Australia; Regional Director PZ Cussons Europe, Asia, South Pacific; Managing Director PZ Cussons UK; General Manager, Colgate Palmolive Benelux; as well as holding European and UK Sales Director positions within Colgate Palmolive.

 

Martin Hagen, interim Chairman, commented "I am delighted to welcome Chris to the Board as Chief Executive, he brings extensive skills and deep sector experience and we look forward to working together on the next chapter in the development of Swallowfield".

As a consequence of the above appointment Mr Ian Mackinnon will step down as Chief Executive Officer and a Director of the Company on the 15th July 2013, one month ahead of the date previously announced. He will remain available to help and assist to ensure an orderly handover is completed.

The following information is disclosed in relation to Schedule Two paragraph (g) of the AIM Rules:

 

Mr Christopher Gerard How (aged 53) has been a director of the following companies during the five years preceding the date of this announcement:

 

Current directorships

Previous directorships

New Value Connections Limited

PZ Cussons (UK) Limited

The Sanctuary Spa Holdings Limited

The Sanctuary Spa Group Limited

The Sanctuary Connections Limited

The Sanctuary Products Limited

The Sanctuary at Covent Garden Limited

The Sanctuary Spas Limited

The Sanctuary Licensing Limited

The Sanctuary Marketing Limited

The Sanctuary Limited

The Sanctuary Gym Limited

 

No further information is required to be disclosed pursuant to Schedule Two paragraph (g).

 

For further information please contact:

Swallowfield plc

Martin Hagen, Interim Chairman 01823 662 241

Mark Warren, Group Finance Director 01823 662 241

 

Shaun Dobson/Jenny Wyllie N+1 Singer 0207 496 3000

Alan Bulmer Investor Focus International 07831 654744

Chris Lawrance JBP Public Relations 0117 907 3400

 

Notes to Editors:

Swallowfield plc is a market leader in the development, formulation and supply of cosmetics, toiletries and related household products to the own label and branded sectors. We pride ourselves on being a customer orientated, innovative, flexible and responsive company and combine high quality, competitive products with strong customer service - developing close partnerships with our customers and an in depth knowledge of their requirements.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFIIRAITLIV
Date   Source Headline
13th Apr 20225:19 pmRNSForm 8.3 - Brand Architekts Group PLC
13th Apr 20224:03 pmRNSForm 8.3 - Offeree - InnovaDerma PLC
13th Apr 20223:22 pmGNWForm 8.3 - Brand Architekts Group plc
13th Apr 20229:26 amRNSForm 8.3 - Brand Architekts Group Plc
13th Apr 20228:48 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
12th Apr 20223:21 pmRNSForm 8.3 - Brand Architekts Group plc - Replace
12th Apr 20222:04 pmRNSForm 8.5 (EPT/RI)
12th Apr 20229:34 amRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:18 pmRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:17 pmRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:14 pmRNSForm 8 (OPD) InnovaDerma PLC
11th Apr 20226:10 pmRNSForm 8 (OPD) - Brand Architekts plc
11th Apr 20224:04 pmRNSForm 8.3 - Brand Architekts Group PLC
11th Apr 20229:06 amRNSForm 8.5 (EPT/RI)
8th Apr 20225:15 pmRNSForm 8.3 - Brand Architekts Group PLC
8th Apr 202210:31 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
7th Apr 20222:40 pmRNSForm 8.4 - Roger McDowell
7th Apr 20222:40 pmRNSDirector/PDMR Shareholding
7th Apr 20229:53 amRNSForm 8.5 (EPT/RI)
6th Apr 20221:10 pmRNSForm 8.4 - Roger McDowell
6th Apr 20221:00 pmRNSDirector/PDMR Shareholding
6th Apr 202211:00 amRNSForm 8.3 - Brand Architekts Group PLC
6th Apr 202210:56 amRNSForm 8.5 (EPT/RI)
5th Apr 202211:45 amRNSForm 8.5 (EPT/RI)
4th Apr 202211:18 amRNSForm 8.5 (EPT/RI)
1st Apr 20221:40 pmRNSForm 8.3 - BRAND ARCHITEKTS GROUP PLC
1st Apr 202211:53 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
31st Mar 20222:54 pmRNSForm 8.3 - Brand Architekts Group Plc
31st Mar 20221:26 pmGNWForm 8.3 - Octopus Investments - Brand Architekts Group plc
31st Mar 20229:52 amBUSForm 8.3 - BRAND ARCHITEKTS GROUP PLC
31st Mar 20227:01 amRNSRecommended Merger with InnovaDerma Plc
31st Mar 20227:00 amRNSHalf-year Report
1st Mar 20227:00 amRNSBoard Appointment
14th Feb 202210:07 amRNSHolding(s) in Company
6th Dec 20214:01 pmRNSHolding(s) in Company
6th Dec 20213:56 pmRNSHolding(s) in Company
29th Nov 20213:54 pmRNSResult of AGM
4th Nov 20213:25 pmRNSAnnual Report and Accounts & Notice of AGM
12th Oct 202112:40 pmRNSGrant of Options
6th Oct 20213:51 pmRNSHolding(s) in Company
5th Oct 202111:23 amRNSHolding(s) in Company
4th Oct 20212:31 pmRNSHolding(s) in Company
30th Sep 202110:23 amRNSLaunch of marketplace: The Unexpekted Store
28th Sep 20212:56 pmRNSDirector/PDMR Dealing
28th Sep 20217:00 amRNSFinal Results
16th Sep 20217:00 amRNSNotice of Investor Presentation
20th Jul 20217:00 amRNSTrading Update
2nd Jul 202110:57 amRNSHolding(s) in Company
29th Mar 20217:00 amRNSHolding(s) in Company
26th Mar 20214:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.